Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Licenses Xenomics' US, European Patents for Prenatal Dx

NEW YORK (GenomeWeb News) – Sequenom said today that it has licensed from Xenomics intellectual property for use in prenatal research and diagnostic tests.
The exclusive license gives Sequenom global rights to use certain transrenal fetal nucleic acids in maternal urine for non-invasive prenatal diagnostics and analysis. The technology may be used on a technology-independent basis for “all uses,” excluding the determination of fetal gender solely by the presence of Y chromosome, Sequenom said.
The agreement, which covers the rights to US Patents 6,251,638 and RE 39,920 and European Patent EP 0920539, extends the company’s SEQureDx prenatal diagnostic technology by enabling it to develop products for noninvasive fetal sampling and testing.
Sequenom’s technology is based on other IP it licensed exclusively from Isis Innovation, the Chinese University of Hong Kong, and from Genomic Nanosystems.
Because the license rights are platform-independent, the company said, it may develop and commercialize tests on any platform, not limited to its MassArray system.
Financial terms of the agreement were not disclosed.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.